StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma total assets

Total assets on the balance sheet at the end of each period.

NervGen Pharma's total assets was C$23.21M at Dec 31, 2025. For fiscal 2025 it was C$23.21M, up 19.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$23.21M+19.1%
FY2024Dec 31, 2024C$19.49M+47.2%
FY2023Jan 1, 2024C$13.24M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$23.21M–
Q4 FY2024Dec 31, 2024C$19.49M–
Q4 FY2023Jan 1, 2024C$13.24M–

More NervGen Pharma figures

See a number that looks wrong?